Management of Palpitations After ASD Closure
Introduction to Palpitations Management
- Patients experiencing palpitations after ASD closure require annual clinical follow-up with ECG monitoring and echocardiography to detect atrial arrhythmias, which occur in approximately 15-25% of adult patients post-closure and represent a significant cause of morbidity 1
Diagnostic Evaluation
- Obtain a 12-lead ECG to identify the specific arrhythmia type (atrial fibrillation, atrial flutter, or other supraventricular tachycardia) 2
- Perform transthoracic echocardiography to evaluate device position, residual shunting, pericardial effusion, right ventricular function, and pulmonary artery pressures 2
- Assess for postpericardiotomy syndrome if accompanied by fever, fatigue, chest pain, or abdominal pain, as this may indicate tamponade requiring urgent intervention 1, 2
Risk Stratification
- Age at closure >40 years: Patients repaired after age 40 have significantly higher rates of new-onset and persistent atrial arrhythmias (60% of those with preoperative arrhythmias continue to have them) 3, 4
- Patients <40 years at closure without pre-existing arrhythmias have the best prognosis, with minimal risk of new arrhythmias (0% in some series during 3.8-year follow-up) 3, 4
Treatment Approach
- Catheter ablation is the preferred treatment for cavotricuspid isthmus (CTI)-dependent atrial flutter in post-ASD closure patients, as this mechanism is common and highly amenable to ablation 3, 4
- Refer to an experienced electrophysiology center with three-dimensional mapping capabilities, as both CTI-dependent and scar-related ("incisional") atrial flutter can coexist after surgical repair 3, 4
- Implement rate control and anticoagulation as standard management for atrial fibrillation 3
Long-Term Monitoring
- Annual follow-up is mandatory for all adult patients with post-closure arrhythmias, including clinical assessment for symptoms, ECG monitoring, and echocardiography to assess right ventricular function and pulmonary pressures 1, 2
- More frequent monitoring (every 3-6 months) if pulmonary hypertension, ventricular dysfunction, or recurrent arrhythmias are present 1, 2
Critical Considerations
- Device erosion is rare but serious; new chest pain or syncope with palpitations requires urgent evaluation 2